Published Date: 31-Mar-23
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Antimicrobial Susceptibility Testing Market size is expected to reach $4.9 billion by 2028, rising at a market growth of 5.9% CAGR during the forecast period.
The Drug Discovery & Development segment is showcasing a CAGR of 6.1% during (2022 - 2028). Antimicrobial susceptibility testing is a crucial factor in the drug research and development process. Since it becomes increasingly difficult to treat bacterial infections, antibiotic resistance is a major worldwide health concern. As a result, large pharmaceutical companies are searching for novel methods to manufacture effective medicines against this bacterial resistance.
The Automated Susceptibility Testing Instruments segment is leading the Global Antimicrobial Susceptibility Testing Market by Method in thereby, achieving a market value of $1.8 billion by 2028. The automated device gives microbiology laboratories the precise MIC data that doctors need to confidently choose an efficient antibiotic for critically ill patients while securing subsequent patient care through improved antimicrobial stewardship. By avoiding retests and supporting a decrease in hidden costs, the instant accuracy of automated antimicrobial testing instruments' MIC values gives accurate results.
The Antifungal segment has shown the growth rate of 6.1% during (2022 - 2028). The necessity for standardized procedures for antifungal susceptibility testing and interpretation of data has arisen as a result of the establishment of resistance in clinically relevant fungi & yeasts and the accessibility of new antifungal medicines. In addition, certain yeast forms can now be tested because of standardization and interpretation standards improvements, although MIC testing of molds should only be done in reference labs.
The Hospitals & Diagnostic centers segment is leading the Global Antimicrobial Susceptibility Testing Market by End User in 2021 thereby, achieving a market value of $2.5 billion by 2028. This segment's substantial share is primarily attributable to the availability of well-equipped facilities and trained/skilled technicians, the increase in hospital-acquired infections, and initiatives leading manufacturers take to sell AST products through diagnostic laboratories and hospitals. The growing number of hospitals in key markets, and also the prevalence of antifungal testing in hospitals & diagnostic laboratories, is rising.
The Manual Laboratory Instruments segment has shown the growth rate of 5.4% during (2022 - 2028). Demand for traditional antimicrobial susceptibility testing techniques is driven by the increasing use of antimicrobial susceptibility testing to provide a focused antimicrobial therapy for patients and the advent of more antibiotic-resistant instances. The market for manual antimicrobial susceptibility testing & related products is fueled by the increasing penetration of the disc diffusion technique and the development of susceptibility plates.
The North America market dominated the Global Antimicrobial Susceptibility Testing Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.8 billion by 2028. The Europe market is exhibiting a CAGR of 5.5% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 6.4% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/antimicrobial-susceptibility-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
By End User
Unique Offerings from KBV Research
North America Antimicrobial Susceptibility Testing Market Future Scope & Opportunities 2022-2028
Europe Antimicrobial Susceptibility Testing Market Size & Growth Forecast 2022-2028
Asia Pacific Antimicrobial Susceptibility Testing Market Size, Share & Industry Outlook to 2028
LAMEA Antimicrobial Susceptibility Testing Market Growth, Trends & Forecasts 2022-2028